SFX by Ex Libris Inc.

Title:	Biological action of leptin as an angiogenic factor
Source:	Science [0036-8075] Sierra-Honigmann, M R yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kannan, RY Y. "Silsesquioxane nanocomposites as tissue implants." Plastic and reconstructive surgery 119.6 (2007): 1653-1662.
description	2.	Guy-Grand, B. "A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction." Nature 392.6674 (1998): 398-401.
description	3.	Nakagawa, M.. "Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts." FEBS letters 473.2 (2000): 161-164.
description	4.	Chua, S C C. "Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor." Science 271.5251 (1996): 994-6.
description	5.	Garcia-Cardena, G. "Dynamic activation of endothelial nitric oxide synthase by Hsp90." Nature 392.6678 (1998): 821-824.
description	6.	Butler, Alexander M J. "The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study." Biomaterials 27.9 (2006): 1971-9.
description	7.	Friedman, J M M. "Leptin and the regulation of body weight in mammals." Nature 395.6704 (1998): 763-70.
description	8.	Friedman, Jeffrey M M. "The function of leptin in nutrition, weight, and physiology." Nutrition reviews 60.10 (2002): 10-14.
description	9.	Kannan, Ruben Y Y. "The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites - An in vitro study." Cell Biochemistry and Biophysics 45.2 (2006): 129-136.
description	10.	Kannan, Mike Y. "The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite." Biomacromolecules 7.1 (2006): 215-223.
description	11.	Kannan, Alexander M Y. "Polyhedral oligomeric silsesquioxane nanocomposites: The next generation material for biomedical applications." Accounts of chemical research 38.11 (2005): 879-884.
description	12.	Montague, S. "Congenital leptin deficiency is associated with severe early-onset obesity in humans." Nature 387.6636: 903-908.
description	13.	Kidane, A. "Flow behaviour of a POSS biopolymer solution." Biorheology 44.4 (2007): 265-272.
description	14.	Lee, J M H. "Abnormal splicing of the leptin receptor in diabetic mice." Nature 379.6566 (1996): 632-635.
description	15.	Ranganathan, S. "Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects." Nature medicine 1.11 (1995): 1155-61.
description	16.	Jeanrenaud, B. "The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals." Diabetes 45.10 (1996): 1446-50.
description	17.	Shah, V. "Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat." Gastroenterology 117.5 (1999): 1222-1228.
description	18.	Phillips, M S S. "Leptin receptor missense mutation in the fatty Zucker rat." Nature genetics 13.1 (1996): 18-9.
description	19.	Zhang, Y.. "Positional cloning of the mouse obese gene and its human homologue." Nature 372.6505 (1994): 425-432.
description	20.	Min, J. "Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells - Concomitant increase of angiogenic responses to RANK ligand." The Journal of biological chemistry 278.41 (2003): 39548-39557.